Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(14 sites) Argentina
Helios Salud, Buenos Aires Panama
Hospital del Niño, Panama City South Africa
University of Stellenbosch, Cape Town Enhancing Care Foundation, Durban WITS RHI Research Centre, Johannesburg Rahima Moosa Mother and Child Hospital, Johannesburg Be Part Yoluntu Centre, Paarl The Aurun Institute, Pretoria Perinatal HIV Research Unit, Soweto Thailand
Faculty of Medicine - Mahidol University, Bangkok Noi Khon Kaen University, Khon Kaen Uganda
Joint Clinical Research Centre, Kampala Baylor College of Medicine, Kampala Zimbabwe
University of Zimbabwe Clinical Research Centre, Harare